Meghan Menges

832 total citations
16 papers, 106 citations indexed

About

Meghan Menges is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Meghan Menges has authored 16 papers receiving a total of 106 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Meghan Menges's work include CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Meghan Menges is often cited by papers focused on CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (3 papers) and Multiple Myeloma Research and Treatments (3 papers). Meghan Menges collaborates with scholars based in United States and Canada. Meghan Menges's co-authors include Frederick L. Locke, Michael D. Jain, Rawan Faramand, Marco L. Davila, Joel G. Turner, Mohammad Hussaini, Ling Cen, Claudio Anasetti, Taiga Nishihori and Kayla Reid and has published in prestigious journals such as Blood, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Meghan Menges

12 papers receiving 105 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meghan Menges United States 8 89 50 27 25 21 16 106
Anna M. Sureda Spain 3 127 1.4× 51 1.0× 35 1.3× 27 1.1× 23 1.1× 6 145
Nicole Verdun United States 4 130 1.5× 54 1.1× 40 1.5× 37 1.5× 31 1.5× 7 175
Diana Bouhassira United States 4 84 0.9× 30 0.6× 28 1.0× 30 1.2× 24 1.1× 7 125
Yaoyao Lou China 4 83 0.9× 38 0.8× 26 1.0× 12 0.5× 21 1.0× 7 101
Jinlong Xu China 6 139 1.6× 37 0.7× 51 1.9× 42 1.7× 41 2.0× 16 177
Yue Tan China 6 151 1.7× 39 0.8× 62 2.3× 45 1.8× 29 1.4× 10 171
John C. Molina United States 7 145 1.6× 29 0.6× 26 1.0× 19 0.8× 20 1.0× 21 174
Alexis Cuffel France 6 105 1.2× 45 0.9× 20 0.7× 60 2.4× 34 1.6× 7 140
Juan Luis Reguera Spain 5 118 1.3× 27 0.5× 28 1.0× 20 0.8× 23 1.1× 7 139
Bruce L. Levine United States 4 158 1.8× 75 1.5× 37 1.4× 37 1.5× 27 1.3× 6 171

Countries citing papers authored by Meghan Menges

Since Specialization
Citations

This map shows the geographic impact of Meghan Menges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan Menges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan Menges more than expected).

Fields of papers citing papers by Meghan Menges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan Menges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan Menges. The network helps show where Meghan Menges may publish in the future.

Co-authorship network of co-authors of Meghan Menges

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan Menges. A scholar is included among the top collaborators of Meghan Menges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan Menges. Meghan Menges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Naderinezhad, Samira, et al.. (2025). Humanin-like 8 regulates metabolic fitness and anti-apoptotic programming in CD19 CAR-T cells. Blood. 146(Supplement 1). 5906–5906.
2.
Freeman, Ciara L., Meghan Menges, Hien Liu, et al.. (2025). Enhanced CAR-T cell function and mitochondrial fitness from earlier unfractionated stem cell product in multiple myeloma. Molecular Therapy. 33(8). 3576–3589. 1 indexed citations
3.
Menges, Meghan, Elliot Merritt, Omar Castañeda Puglianini, et al.. (2025). Advancing Soluble BCMA Quantification in Immunotherapy: Analytical Validation of ELLA Versus ELISA for Predicting Toxicity and Response. Clinical Lymphoma Myeloma & Leukemia. 25. S143–S143.
4.
Ziccheddu, Bachisio, Michael D. Jain, Monika Chojnacka, et al.. (2024). Intrinsic Tumor Drivers and Immune Escape Mechanisms in CD19 CAR T-Cell Therapy Resistance for Aggressive Large B Cell Lymphoma. Blood. 144(Supplement 1). 232–232. 2 indexed citations
5.
6.
Freeman, Ciara L., Meghan Menges, Jeffrey Edelman, et al.. (2023). Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma. Clinical Cancer Research. 29(22). 4575–4585. 8 indexed citations
7.
Ionescu, Filip, Bijal Shah, Meghan Menges, et al.. (2023). Cladribine and Cyclophosphamide Lymphodepletion Prior to Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma. Blood. 142(Supplement 1). 4884–4884.
8.
Locke, Frederick L., Michael D. Jain, Joel G. Turner, et al.. (2023). CD19 Intron Retention Is Mechanism of CAR-T Treatment Resistance in Non-Hodgkin Lymphoma. Blood. 142(Supplement 1). 3506–3506. 1 indexed citations
9.
Jain, Michael D., Bachisio Ziccheddu, Caroline A. Coughlin, et al.. (2022). Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma. Blood. 140(5). 491–503. 36 indexed citations
10.
Lee, Dasom, Meghan Menges, Aleksandr Lazaryan, et al.. (2022). Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy. Transplantation and Cellular Therapy. 29(4). 277.e1–277.e9. 14 indexed citations
11.
Menges, Meghan, et al.. (2022). CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production. Frontiers in Immunology. 13. 1007042–1007042. 10 indexed citations
12.
Hansen, Doris K., Kenneth L. Gage, Rachid Baz, et al.. (2022). High Metabolic Tumor Volume Is Associated with Higher Toxicity and Decreased Efficacy of BCMA CAR-T Cell Therapy in Multiple Myeloma. Blood. 140(Supplement 1). 10402–10404. 9 indexed citations
13.
14.
15.
Jain, Michael D., Meghan Menges, Rawan Faramand, et al.. (2019). Tumor Inflammation and Myeloid Derived Suppressor Cells Reduce the Efficacy of CD19 CAR T Cell Therapy in Lymphoma. Blood. 134(Supplement_1). 2885–2885. 9 indexed citations
16.
Locke, Frederick L., Meghan Menges, Anandharaman Veerapathran, et al.. (2015). Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma. Journal for ImmunoTherapy of Cancer. 3(1). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna M. Sureda Breakdown of academic impact, for papers by Nicole Verdun Breakdown of academic impact, for papers by Diana Bouhassira Breakdown of academic impact, for papers by Yaoyao Lou Breakdown of academic impact, for papers by Jinlong Xu Breakdown of academic impact, for papers by Yue Tan Breakdown of academic impact, for papers by John C. Molina Breakdown of academic impact, for papers by Alexis Cuffel Breakdown of academic impact, for papers by Juan Luis Reguera Breakdown of academic impact, for papers by Bruce L. Levine
Rankless by CCL
2026